Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.
Br J Haematol
; 204(3): 877-886, 2024 Mar.
Article
in En
| MEDLINE
| ID: mdl-37952982
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Azacitidine
/
Leukemia, Myeloid, Acute
Limits:
Humans
Language:
En
Journal:
Br J Haematol
Year:
2024
Type:
Article
Affiliation country:
United States